Wpisz informacje, które znasz



M.n.g. Dukes


Elsevier Science

Data premiery:


693,00 PLN
Wysyłamy w 35 dni

Opis produktu

As one of the most massive and successful business sectors the pharmaceutical industry is a potent force for good in the community yet its behaviour is frequently questioned: could it serve society at large better than it has done in the recent past? Its own internal ethics both in business and science may need a careful reappraisal as may the extent to which the law administrative civil and criminal succeeds in guiding (and where neccessary contraining) it. brbrThe rules of behavior that may be considered to apply to todays pharmaceutical industry have emerged over a very long period and the process goes on. Even the immensely detailed standards for quality safety and efficacy laid down in drug law and regulation during the second half of the twentieth century have their limitations as tools for ensuring that the public interest is well served. In particular national and regional regulatory agencies are heavily dependent on industrial data for their decisionmaking their standards and competence vary and even the existing network of agencies does not cover the entire world. What is more there are many areas of law and regulation affecting the industry concerning for example the pricing of medicines the conduct of clinical studies the health protection of workers and concern for the environment. In some fields it is indeed hardly possible to maintain standards through regulation.brbrProfessor N.M. Graham Dukes a physician and lawyer with long term experience in industrial research management academic study and international drug policy provides here a powerfully documented analysis into the way this industry thinks acts and is viewed and examines the current trends pointing to change. brbr*Provides a balanced picture of the current role of the pharmaceutical industry in societybr*Includes indices of conventions laws and regulations: as well as judicial and disciplinary casesbr*This is the only book addressing the legal implications of big pharma activities and ethical standards ...Although Dukes doesnt attempt to catalogue all relevant laws he provides categories and examples that serve as a useful starting point for understanding the types of policies and laws that should be considered in particular cases. In addition Dukes includes stories that led to the adoption of some of the laws and policies which helps to make the process more accessible to the reader.br Jeremy Sugarman M.D. M.P.H. Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) brbr...a measured walk through most of the beterknown public policy issues revolving around drug research marketing and use.br PharmaceuticalCommerce.com (2006)

Data Publikacji: 2005-11-04
Wymiary: 240 x 165 (mm x mm x mm x gr)

Dodaj recenzję

Zaloguj sie, aby móc dodać swoją recenzję.



Tytułów w bazie:

1 116 357

Ostatnia aktualizacja:



mail: prus@prus24.pl

telefon: (22) 826-18-35

Copyright © 2001-2019 Główna Księgarnia Naukowa im. B. Prusa. Wszelkie prawa zastrzeżone.
Home   /   Informacje   /   Kontakt
Projekt i realizacja: